Is AVCTF or VYM a better dividend investment in 2026?

AVCTF currently yields 230.65% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: AVCTF offers higher current income.

What is the dividend yield difference between AVCTF and VYM?

AVCTF has a forward dividend yield of 230.65% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 228.24 percentage points.

Home › Compare › AVCTF vs VYM

AVCTF vs VYM: Dividend Comparison 2026

AVCTF yields 230.65% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVCTF wins by $279.19M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVCTF

● Live price

230.65%

Share price

$0.87

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$279.22M

Annual income

$150,694,330.53

Full AVCTF calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — AVCTF vs VYM

📍 AVCTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVCTF	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVCTF + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVCTF pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVCTF

Annual income on $10K today (after 15% tax)

$19,605.58/yr

After 10yr DRIP, annual income (after tax)

$128,090,180.95/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, AVCTF beats the other by $128,089,944.18/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVCTF + VYM for your $10,000?

AVCTF: 50%VYM: 50%

100% VYM50/50100% AVCTF

Portfolio after 10yr

$139.62M

Annual income

$75,347,304.53/yr

Blended yield

53.97%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVCTF buys

VYM buys

No recent congressional trades found for AVCTF or VYM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVCTFVYM

Forward yield	230.65% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$279.22M ✓	$27.8K
Annual income after 10y	$150,694,330.53 ✓	$278.55
Total dividends collected	$265.09M ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: AVCTF vs VYM ($10,000, DRIP)

Year	AVCTF Portfolio	AVCTF Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$33,765	$23,065.39	$11,151	$241.44	+$22.6K → AVCTF
2	$108,915	$72,786.16	$12,413	$246.79	+$96.5K → AVCTF
3	$335,962	$219,422.65	$13,794	$251.79	+$322.2K → AVCTF
4	$992,036	$632,556.65	$15,306	$256.47	+$976.7K → AVCTF
5	$2,807,112	$1,745,633.43	$16,960	$260.84	+$2.79M → AVCTF
6	$7,619,990	$4,616,380.77	$18,768	$264.92	+$7.60M → AVCTF
7	$19,864,891	$11,711,501.13	$20,745	$268.71	+$19.84M → AVCTF
8	$49,789,295	$28,533,861.41	$22,905	$272.24	+$49.77M → AVCTF
9	$120,113,025	$66,838,479.41	$25,265	$275.51	+$120.09M → AVCTF
10	$279,215,267	$150,694,330.53	$27,842	$278.55	+$279.19M → AVCTF

AVCTF vs VYM: Complete Analysis 2026

AVCTF — Stock

Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive to cleavage by fibroblast activation protein alpha; drug development collaboration with LG Chem Life Sciences; partnership with Tufts University School of Medicine for developing Affimer drug conjugate therapies; licensing agreement with POINT Biopharma Inc. for the development of tumour activated radiopharmaceuticals; and drug development partnership with AffyXell to develop engineered mesenchymal stem cells to treat autoimmune diseases. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.

Full AVCTF Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this AVCTF vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVCTF vs SCHD AVCTF vs JEPI AVCTF vs O AVCTF vs KO AVCTF vs MAIN AVCTF vs VIG AVCTF vs DGRO AVCTF vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.